top of page
AdobeStock_328733419.jpeg

OUR PORTFOLIO

We are partnering with companies and entrepreneurs that are advancing frontiers in science and technology.

epsilogen2.png

Epsilogen

Boston, MA

​

Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer.

​

www.epsilogen.com

asession.png

Acesion Pharma

Copenhagen, Denmark

​

Acesion Pharma is developing a next generation antiarrhythmic drug that targets the SK channel to treat atrial fibrillation (A-fib) without causing significant extracardiac and cardiac related adverse events.

​

www.acesionpharma.com

odyssey2.png

Odyssey Therapeutics

Boston, MA

​

Odyssey is creating next generation precision medicines for patients with cancer and inflammatory diseases by targeting key signaling nodes that are critical drivers of disease.

​

www.odysseytx.com

vittoria.png

VITTORIA Biotherapeutics

Philadelphia, PA

 

Harnessing the unrealized potential of CD5 as a novel checkpoint for cell therapies.

​

www.vittoriabio.com

shira2.png

SHIRATRONICS

Minneapolis, MN

 

​Transform the lives of those living with Chronic Migraine.​

​

www.shiratronics.com

nuvig2.jpg

Nuvig Therapeutics

Menlo Park, CA

​

Developing a first-in-class Fc fragment
immunomodulator to treat autoimmune diseases.​

​

www.nuvigtherapeutics.com

bottom of page